Skip to main content
Premium Trial:

Request an Annual Quote

Two Japanese BLIS Licenses Mark Biotique s Entre Into Asia-Pacific Market

NEW YORK, Sept. 9 - Biotique Systems today said Fujisawa Pharmaceutical, Ono Pharmaceutical, and Metabolex have signed annual software licenses for its BLIS technology.

 

Two of the licenses also represents Biotique's entrée into the Asia-Pacific pharma market: Fujisawa and Ono are based in Japan.

 

Each of the three deals gives provides access to one of Biotique's local-integration systems, which is scaleable and can be linked to multiple-research sites.

 

Click here for more information.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.